Research Videos
Within Trials@Home we aim to share learnings on implementation of remote technologies and approaches in the context of decentralised clinical trials. Our army of talented young researchers prepared short videos where they share the highlights of their research. These videos were created to share these outputs with the consortium, but we think they are too good not to share them 😉
Listen to Amos de Jong about his study on the on facilitators and barriers for DCTs from a regulatory perspective.
Implementation of new innovative approaches in clinical practice are always accompanied by (regulatory) challenges. In the IMI Trials@Home project, we reached out to European ethics committees and asked them to conduct a (mock) review of our decentralised clinical trial approach. The feedback was used to inform design adjustments for the RADIAL trial. Check out this video where Tessa van Rijssel tells more about her project.
In this video, Julia Kopanz talks about her ongoing research into patient preferences for decentralised clinical trial approaches.
Within the IMI Trials@Home project we were curious to know more about the implementation of decentralized trial activities in clinical trials. To learn more, we investigated which and if decentralised and on-site conduct of trial activities were reported in CT protocols with a trial start date in 2019 or 2020.
Interested in our findings? Then check out this video where Renske Grupstra tells more about this project.
In this video our Utrecht University colleague Yared Santa Ana Téllez talks about our recent paper ‘Decentralised, patient-centric, site-less, virtual, and digital clinical trials? From confusion to consensus’, also co-authored by Bart Lagerwaard, Amos de Jong, Helga Gardarsdottir, Diederick (Rick) E. Grobbee, MD, PhD, FESC, Kim Hawkins, Megan Heath.
In this specific project, we interviewed members of European Health Technology Assessment bodies to identify opportunities and challenges of DCTs from an HTA perspective. Check out this video where Nadi Shahid tells more about her project.
Decentralised clinical trials (DCTs) are one way to make trials more accessible. Within the IMI Trials@Home project we were curious to hear from different stakeholders their views on conducting DCTs, including lessons learned, the advantages and disadvantages.
Interested in our findings? Then check out this video where Rachel Copland tells more about this project.
An important part of the IMI Trials@Home project is to assess the availability of technologies that can be used to support conduct of decentralised clinical trials. To learn more, our work package TECH team conducted a study where they identified specific tools and technologies that can be used for this purpose. Curious to know more, then listen to Simone Huber from the FH Joanneum University of applied sciences tell you more about this study.